MedTrace Logo

The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients

NCT06411925 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 296

Last updated 2025-09-23

No results posted yet for this study

Summary

Clinical Study to Evaluate the Efficacy and Safety of Atock Dry Syrup with Acute bronchial Patients

Conditions

  • Acute Bronchitis

Interventions

DRUG

Atock Dry Syrup with placebo patch

Atock Dry syrup (TID) with placebo patch (QD)

DRUG

Tulobuterol patch with placebo dry syrup

Tulobuterol patch (QD) with placebo dry syrup (TID)

Sponsors & Collaborators

  • SamA Pharmaceutical Co., Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-10
Primary Completion
2027-07-31
Completion
2027-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06411925 on ClinicalTrials.gov